However, long-term safety data including cardiovascular outcomes, heart-rate effects, and optimal dosing are still being gathered in Phase 3 studies, and no definitive safety conclusions can be drawn at this stage
To view or add a comment, sign in Novo Nordisk Q1 adjusted operating profit hit 32.86 billion Danish crowns, beating the 28.74 billion crown forecast, driven by Wegovy strength
Were talking twelve people in some
Yes, were talking about the dreaded meno belly. You can largely thank your declining estrogen levels for menopause-related weight gain
Patients taking both medications may require closer monitoring of blood clotting levels
Balancing profitability with affordability can be challenging, and some may argue that Eli Lilly could do more to lower prices and make drugs more accessible